Revolution Medicines, Inc. · NASDAQ:RVMD
Dapice Joshua J. reported a 5.10% stake in Revolution Medicines, Inc. (Schedule 13G)
Event Apr 12, 2024 · Filed May 15, 2025
Dapice Joshua J. reported a 5.10% stake in Revolution Medicines, Inc., 8,376,225 shares, as a passive investor on Apr 12, 2024. Filed May 15, 2025 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 8,376,225
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 29 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Farallon Capital Partners, L.P. | 0.30% | 441,274 |
| Farallon Capital Institutional Partners, L.P. | 0.50% | 838,234 |
| Farallon Capital Institutional Partners II, L.P. | 0.10% | 232,666 |
| Farallon Capital Institutional Partners III, L.P. | 0.10% | 90,569 |
| Four Crossings Institutional Partners V, L.P. | 0.10% | 142,049 |
| Farallon Capital Offshore Investors II, L.P. | 0.90% | 1,441,714 |
| Farallon Capital (AM) Investors, L.P. | 0.10% | 85,101 |
| Farallon Capital F5 Master I, L.P. | 0.20% | 343,185 |
| Farallon Healthcare Partners Master, L.P. | 2.90% | 4,761,433 |
| Farallon Partners, L.L.C. | 4.90% | 8,033,040 |
| Farallon Institutional (GP) V, L.L.C. | 0.10% | 142,049 |
| Farallon F5 (GP), L.L.C. | 0.20% | 343,185 |
| Farallon Healthcare Partners (GP), L.L.C. | 2.90% | 4,761,433 |
| Dapice Joshua J. | 5.10% | 8,376,225 |
| Dreyfuss, Philip D. | 5.10% | 8,376,225 |
| Dunn Hannah E. | 5.10% | 8,376,225 |
| Fried, Richard B | 5.10% | 8,376,225 |
| Gehani, Varun N. | 5.10% | 8,376,225 |
| Giauque, Nicolas | 5.10% | 8,376,225 |
| Kim, David T. | 5.10% | 8,376,225 |
| Linn, Michael G. | 5.10% | 8,376,225 |
| Patel, Rajiv A. | 5.10% | 8,376,225 |
| Roberts, Jr., Thomas G. | 5.10% | 8,376,225 |
| Saito Edric C. | 5.10% | 8,376,225 |
| Seybold, William | 5.10% | 8,376,225 |
| Short Daniel S. | 5.10% | 8,376,225 |
| Spokes, Andrew J. M. | 5.10% | 8,376,225 |
| Warren, John R. | 5.10% | 8,376,225 |
| Wehrly, Mark C. | 5.10% | 8,376,225 |
Source
Related
- Revolution Medicines, Inc.
- Dapice Joshua J.
- Revolution Medicines, Inc. shareholders
- Schedule 13G/A · Dapice Joshua J. · Feb 9, 2026
- Schedule 13G/A · Dapice Joshua J. · May 15, 2025
- Schedule 13G/A · Dapice Joshua J. · May 15, 2025
- Form 4 · Sandler Alan B. · Oct 1, 2026
- Form 4 · Cislini Jeff · Sep 29, 2026
- Form 4 · Mancini Anthony · Sep 28, 2026
- Form 4 · Anderson Elizabeth M · Sep 24, 2026
- Form 4 · Mancini Anthony · Sep 22, 2026